# ROX Index and ROX Vector to Predict Nasal High Flow / Continuous Positive Airway Pressure Failure in Neonates

> **NCT05036161** · — · UNKNOWN · sponsor: **Erebouni Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Predictive Value of Tests

## Interventions

- **OTHER:** Nasal high flow
- **OTHER:** Continuous Positive Airway Pressure

## Key facts

- **NCT ID:** NCT05036161
- **Lead sponsor:** Erebouni Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-06
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05036161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05036161, "ROX Index and ROX Vector to Predict Nasal High Flow / Continuous Positive Airway Pressure Failure in Neonates". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05036161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*